March 30, 2025
CHICAGO — Semaglutide, a glucagon-like peptide (GLP-1) receptor agonist, has shown convincing benefits in yet another population: patients with peripheral arterial disease (PAD). In the STRIDE […]
March 29, 2025
The addition of lorundrostat, an investigational drug, to the treatment regimen of people with well-treated but uncontrolled and resistant hypertension could be beneficial, new data show. […]
March 29, 2025
Wearable technologies such as smartwatches are providing physicians with new ways to monitor their patients’ health and detect cardiovascular risk factors. Metrics like daily step totals […]
March 28, 2025
Individuals testing positive for human papillomavirus (HPV) had a 40% greater risk for overall cardiovascular disease (CVD) than HPV-negative individuals, based on the data from nearly […]
March 28, 2025
(Reuters) -Milestone Pharmaceuticals said on Friday the U.S. health regulator had declined to approve its nasal spray to treat a type of heart condition and had […]
March 27, 2025
An investigation has found a “concerning level of variation” in how 12-lead electrocardiogram (ECG) skills are taught in UK undergraduate paramedic programmes. A report by the […]
March 27, 2025
New clinical guidance to help cardiologists navigate the complexity of cardiogenic shock and assess possible cases within the first hour after onset introduces a memory aid […]
March 26, 2025
TOPLINE: Industry marketing for angiotensin receptor–neprilysin inhibitors (ARNis) and sodium-glucose cotransporter 2 inhibitors (SGLT2is) targeted at cardiologists was associated with increased prescription of these medications but […]
March 26, 2025
Two new studies add to the growing body of evidence linking cannabis to worse cardiovascular health outcomes. Although more research is needed to determine the amount […]